CClinicalTrials.gg
CompletedNCT05318703Updated Mar 22, 2023

Virtual Exercise For Older Adults With Mild Cognitive Impairment

An interventional study of tai ji quan and Stretching in Mild Cognitive Impairment, sponsored by Oregon Research Institute. Completed at 1 site in United States. Open to participants aged 65 Years to 95 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-22.

Sponsored by Oregon Research Institute · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jan 2021, registered Mar 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
65 Years to 95 Years
Sex
All
01

Study summary

This project is designed to develop and evaluate an Internet-based exercise intervention (tai ji quan Moving to Improve Brain Health) using real-time videoconferencing for older adults with mild cognitive impairment (MCI).

Read the detailed description

The project has three major goals: (a) transforming an in-person tai ji quan brain health intervention protocol into an online (virtual) class protocol and evaluating its feasibility of implementation in older adults with MCI, (b) developing and evaluating online assessment and data ascertainment procedures that encompass cognitive and physical performance measures, and (c) conducting a randomized controlled trial comparing the effectiveness of this new online intervention protocol with a conventional stretching exercise group in older adults with MCI.

02

Conditions studied

  • Mild Cognitive Impairment

Keywords

  • tai chi, ehealth, older adults, cognitive impairment
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 69 is close to the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Oregon Research Institute is the lead sponsor of 70 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Self-report a change or decline in memory (corroborated by an informant)
  • Record a score of ≤0.5 on the Clinical Dementia Rating (CDR) scale (with information derived from both the participant and an informant)
  • Show no major impairment in cognitive function as indexed by a score of ≥24 on the Mini Mental State Evaluation (MMSE).

Exclusion criteria

Exclusion criteria:

  • Have participated in a rigorous and structured physical activity or exercise program (including Tai Ji Quan) in the past 6 months,
  • Show major signs of depression as indicated by a score of ≥5 on the Geriatric Depression Scale
  • Have major medical or physical conditions that preclude exercise, as determined by their healthcare practitioner
  • Being unable to follow the consent process or sign the study consent form.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
69 participants (actual)

Study arms

  • Experimental
    cognitively enhanced tai ji quan

    Participants receive a cognitively enhanced tai ji quan exercise intervention for 16 weeks.

    Behavioral: tai ji quan

  • Active comparator
    stretching exercise

    Participants receive a stretching exercise intervention for 16 weeks.

    Behavioral: Stretching

Interventions

  • Behavioraltai ji quan

    cognitively enhanced tai ji quan exercise

  • BehavioralStretching

    Stretching exercise

06

What researchers measure

Primary outcomes

  1. (a) Total number of intervention sessions taught by instructors over the course of study (recorded by a class check sheet) and (b) total number of classes attended by participants over the course of intervention as recorded by class attendance sheet

    assess the extent to which interventionists successfully implement the prespecified exercise training protocol.

    Time frame: 16 weeks

  2. number of dropouts from the intervention and study as assessed by a study recording sheet

    assess intervention dropout rate and retention rate

    Time frame: 16 weeks

  3. Number of participants expressing intervention program satisfaction as assessed by a self-report survey

    assess the program acceptability among tai ji quan participants

    Time frame: 16 weeks

  4. Change in global cognitive function assessed by Montreal Cognitive Assessment

    assess change from baseline cognitive function at 16 weeks

    Time frame: baseline, 16 weeks

  5. Change in attention and working memory as assessed by Digit Span - forward and backward

    assess change from baseline in attention and working memory at 16 weeks

    Time frame: baseline, 16 weeks

  6. Change in dual-task cost as assessed by Timed Up and Go with a cognitive task

    assess change from baseline in the ability to stand up from a chair, walk, and sit down while performing an arithmetic task at 16 weeks

    Time frame: baseline, 16 weeks

  7. Change in executive function as assessed by Trail Making B

    assess change from baseline executive function at 16 weeks

    Time frame: baseline, 16 weeks

  8. Change in executive function as assessed by Category Fluency for Animals

    assess change from baseline executive function at 16 weeks

    Time frame: baseline, 16 weeks

  9. Change in cognitive functioning assessed by Everyday Cognition

    assess change from baseline cognitive functioning at 16 weeks

    Time frame: baseline, 16 weeks

  10. Change in physical performance as measured by Timed Up and Go test

    assess change from baseline in the ability to stand up from a chair, walk, and sit down at 16 weeks

    Time frame: baseline, 16 weeks

  11. change in leg strength as assessed by 30-second chair stand test

    assess change from baseline in leg strength at 16 weeks

    Time frame: baseline, 16 weeks

  12. Change in balance using a 4-stage balance test

    assess change from baseline in balance at 16 weeks

    Time frame: baseline, 16 weeks

Secondary outcomes

  1. Change in depression as assessed by Geriatric Depression scale

    assess change from baseline in the level of depression at 16 weeks

    Time frame: baseline, 16 weeks

  2. Change in physical activity as assessed by International Physical Activity Questionnaire

    assess change from baseline in physical activity at 16 weeks

    Time frame: baseline, 16 weeks

  3. Change in quality of life as assessed by EuroQol (EQ-5D-3L)

    assess change from baseline in quality of life at 16 weeks

    Time frame: baseline, 16 weeks

07

Study locations

1 site
  • Oregon Research Institute
    Eugene, Oregon 97403, United States
08

References and documents

Individual participant data

Plan to share: Yes — There is a plan to make IPD and related data dictionaries available.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05318703
Lead sponsor
Oregon Research Institute
Responsible party
Sponsor
First posted
Apr 8, 2022
Start date
Jan 20, 2021
Primary completion
Aug 30, 2022
Completion
Oct 30, 2022
Last update
Mar 22, 2023

Study contacts

Fuzhong Li, Ph.D.
principal investigator · Oregon Research Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion